Almuradova D.M.; Ravshanova N.B.; Abdurakhimov A.I. Clinical Outcomes of EGFR-Targeted Therapy With Erlotinib Versus Polychemotherapy in NSCLC: A Statistical Analysis. ijmscr 2026, 6, 82-86.